Норвегия -
норвежки -
Statens legemiddelverk
zopiklon mylan 7.5 mg
mylan ab - zopiklon - tablett, filmdrasjert - 7.5 mg
Норвегия -
норвежки -
Statens legemiddelverk
paracetduo 500 mg / 65 mg
karo pharma oslo as - paracetamol / koffein - tablett - 500 mg / 65 mg
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
pheburane
eurocept international b. v. - sodium phenylbutyrate - carbamoyl-fosfat syntase jeg mangel sykdom - ulike alimentary tract and metabolism products - behandling av kronisk ledelse av urea-syklus lidelser.
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
prialt
esteve pharmaceuticals gmbh - ziconotid - injections, spinal; pain - analgetika - ziconotid er indisert for behandling av alvorlig kronisk smerte hos pasienter som krever intratekal (it) analgesi.
Норвегия -
норвежки -
Statens legemiddelverk
prialt 100 mikrog/ ml
abacus medicine a/s - zikonotidacetat - infusjonsvæske, oppløsning - 100 mikrog/ ml
Европейски съюз -
норвежки -
EMA (European Medicines Agency)
rozlytrek
roche registration gmbh - entrectinib - cancer; carcinoma, non-small-cell lung - antineoplastiske midler - rozlytrek as monotherapy is indicated for the treatment of adult and paediatric patients 12 years of age and older with solid tumours expressing a neurotrophic tyrosine receptor kinase (ntrk) gene fusion,who have a disease that is locally advanced, metastatic or where surgical resection is likely to result in severe morbidity, andwho have not received a prior ntrk inhibitorwho have no satisfactory treatment options. rozlytrek as monotherapy is indicated for the treatment of adult patients with ros1 positive, advanced non small cell lung cancer (nsclc) not previously treated with ros1 inhibitors.